AzTrials
AzTrials

IntubationETIDNCT02277652

Endotracheal Intubation Devices

A study testing The Miller Laryngoscope, The Bonfils intubation fibrescope and The GlideScope Ranger in people with Intubation, run by International Institute of Rescue Research and Education at 1 site in Poland.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The purpose of this study was to compare the four different intubation devices in 6 different scenarios. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Intubation
What is being tested?
The Miller Laryngoscope, The Bonfils intubation fibrescope and The GlideScope Ranger
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
120 participants
Where
1 sitePoland
Study dates
Oct 2014to Nov 2014
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • give voluntary consent to participate in the study
  • minimum 1 year of work experience in emergency medicine
  • experienced emergency medical personnel (paramedics, nurses, physicians)

Who cannot join

  • not meet the above criteria
  • wrist or low back diseases

Trial locations and contacts

1 site in 1 country.

Poland1 site, 1 recruiting
  • International Institute of Rescue Research and Education

    Warsaw, Masovia, 03-122

    Lukasz Szarpak, (+48)500186225, lukasz.szarpak@gmail.com

    Recruiting

Other trials in Poland

About this study

Official title: Comparison of Four Different Endotracheal Intubation Devices Performed by Emergency Medical Professionals: a Manikin Study With 6 Airway Scenarios

The purpose of this study was to compare the four different intubation devices in 6 different scenarios.

Conditions
Intubation
Being tested
The Miller Laryngoscope, The Bonfils intubation fibrescope, The GlideScope Ranger, The Supraglottic Airway Laryngopharyngeal Tube (SALT)

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • The Miller LaryngoscopeDevice

    Direct laryngoscopy

  • The Bonfils intubation fibrescopeDevice

    Optical laryngoscopy

  • The GlideScope RangerDevice

    Videolaryngoscopy

  • The Supraglottic Airway Laryngopharyngeal Tube (SALT)Device

    Blind intubation

Study groups in NCT02277652
Study groupRoleWhat they receive
Scenario 1: Uninterrupted chest compressionsExperimentalEndotracheal intubation (ETI) during pediatric manikin with uninterrupted chest compressions. Chest compression was performed using LUCAS-2 (Physio-Control, USA).
Receives: Device: The Miller Laryngoscope; Device: The Bonfils intubation fibrescope; Device: The GlideScope Ranger; Device: The Supraglottic Airway Laryngopharyngeal Tube (SALT)
Scenario 2: Neutral positionExperimentalETI performed in neutral mannikin head position
Receives: Device: The Miller Laryngoscope; Device: The Bonfils intubation fibrescope; Device: The GlideScope Ranger; Device: The Supraglottic Airway Laryngopharyngeal Tube (SALT)
Scenario 3: Sniffing positionExperimentalETI performed in sniffing mannikin head position
Receives: Device: The Miller Laryngoscope; Device: The Bonfils intubation fibrescope; Device: The GlideScope Ranger; Device: The Supraglottic Airway Laryngopharyngeal Tube (SALT)
Scenario 4: Pharyngeal swellingExperimentalETI performed during mannikin pharyngeal swelling scenario
Receives: Device: The Miller Laryngoscope; Device: The Bonfils intubation fibrescope; Device: The GlideScope Ranger; Device: The Supraglottic Airway Laryngopharyngeal Tube (SALT)
Scenario 5: Swollen tongueExperimentalETI performed during mannikin swollen tongue scenario
Receives: Device: The Miller Laryngoscope; Device: The Bonfils intubation fibrescope; Device: The GlideScope Ranger; Device: The Supraglottic Airway Laryngopharyngeal Tube (SALT)
Scenario 6: Immobilized cervical spineExperimentalETI performed during mannikin immobilized cervical spine scenario
Receives: Device: The Miller Laryngoscope; Device: The Bonfils intubation fibrescope; Device: The GlideScope Ranger; Device: The Supraglottic Airway Laryngopharyngeal Tube (SALT)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Time to intubation

    time from insertion of the blade to the first manual ventilation of the manikin´s lungs. If time of intubation is over than 60 seconds, attempt was recognized as failure.

    Measured: 1 month

Secondary outcomes (4)
  1. Success of intubation

    effectiveness of the first, second and third intubation attempts and overall effectiveness of intubation by participants using four intubation devices. If the examinee failed at all attempts, the case was excluded from the time calculations.

    Measured: 1 month

  2. POGO score

    self-reported percentage of glottis opening (POGO) score

    Measured: 1 month

  3. VAS score

    participants were asked which method they would prefer in a real-life resuscitation.

    Measured: 1 month

  4. Cormack-Lehane grading

    self-reported percentage the vocal cord visualization using the Cormack-Lehane grading (grade 1-4)

    Measured: 1 month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Oct 2014 (estimated)
  2. Study startOct 2014
  3. Primary completionNov 2014 (estimated)
  4. Study completionNov 2014 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
120 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02277652
Sponsor's protocol ID
ETI/2014/03
Acronym
ETID
Status last verified
Nov 2014
First submitted
26 Oct 2014
Last updated
13 Nov 2014
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A study testing The Miller Laryngoscope, The Bonfils intubation fibrescope and The GlideScope Ranger in people with Intubation, run by International Institute of Rescue Research and Education at 1 site in Poland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 13 Nov 2014. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Poland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Lukasz Szarpak ((+48)500186225, lukasz.szarpak@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Time to intubation (time frame: 1 month). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Nov 2014.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in